🔎 Trials Near Me

Beranda › Fibrosis Kistik › Colorado

Uji klinis Fibrosis Kistik di Colorado

17 studi untuk Fibrosis Kistik mencari peserta di lokasi di Colorado.

Kota di Colorado

Teks studi resmi (Bahasa Inggris)

Phase 2 Study to Assess the Safety and Efficacy of ANG003

  • National Jewish Health, Denver
Menerima pesertaFase 2
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07450547

Impact of Sinus Surgery on Individuals With Cystic Fibrosis

  • University of Colorado, Aurora
  • National Jewish Health, Denver
Menerima pesertaStudi observasional
Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT04469439

Sinus Disease in Young Children With Cystic Fibrosis

  • Children's Hospital Colorado, Aurora
Menerima pesertaStudi observasional
Usia 2 hingga 8 · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT06191640

Remote Sputum Collection in Cystic Fibrosis

  • National Jewish Health, Denver
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 19 Agu 2026 · NCT06950892

Streamlined Treatment of Pulmonary Exacerbations in Pediatrics

  • Children's Hospital of Colorado, Aurora
Menerima peserta
Usia 3 hingga 18 · Semua jenis kelamin · Diperbarui 3 Agu 2026 · NCT06654752

Study to Evaluate Biological & Clinical Effects of Significantly Corrected CFTR Function in Infants & Young Children

  • Children's Hospital Colorado, Aurora
Menerima pesertaStudi observasional
Hingga usia 10 · Semua jenis kelamin · Diperbarui 8 Jul 2026 · NCT04509050

TIDES 2.0: Prevalence and Longitudinal Course of Depression, Anxiety, and Behavior Problems in Children With Cystic Fibrosis Under 12 Years of Age

  • Children's Hospital Colorado, Aurora
Menerima pesertaStudi observasional
18 Months – 11 Years · Semua jenis kelamin · Diperbarui 6 Jul 2026 · NCT07048574

4D-710 in Adult Patients With Cystic Fibrosis

  • National Jewish Health, Denver
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 6 Jul 2026 · NCT05248230

GLP-1 Agonist Therapy in Cystic Fibrosis-Related Glucose Intolerance

  • Children's Hospital of Colorado, Aurora
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Mei 2026 · NCT04731272

Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SPL84 in Patients With Cystic Fibrosis

  • National Jewish Health, Denver
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Mei 2026 · NCT06429176

CF Wellness Program

  • National Jewish Health, Denver
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Feb 2026 · NCT07071324

Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)

  • University of Colorado Denver, Aurora
Menerima pesertaStudi observasional
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 10 Feb 2026 · NCT06837181

Health Outcomes of Parents With Cystic Fibrosis-Aim 2

  • National Jewish Health, Denver
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Nov 2025 · NCT06296394

Restarting Triple Therapy With Robust Monitoring for Adverse Events (RETRIAL)

  • Children's Hospital Colorado, Aurora
  • National Jewish Health, Denver
Menerima pesertaStudi observasional
Usia 6 ke atas · Semua jenis kelamin · Diperbarui 3 Nov 2025 · NCT06683092

IV Gallium Study for Patients With Cystic Fibrosis Who Have NTM (ABATE Study)

  • National Jewish Health, Denver
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2025 · NCT04294043

A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators

  • Children's Hospital Colorado, Aurora
  • National Jewish Health, Denver
Menerima pesertaStudi observasional
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2025 · NCT06504589

Study With Phage for CF Subjects With Pseudomonas Lung Infection

  • National Jewish Health, Denver
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Jul 2025 · NCT06998043

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.